Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial-Reference-Cited by-同舟云学术

Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial

Published:2007-05 Issue:5 Volume:82 Page:543-550
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Insull William,Ghali Jalal K.,Hassman David R.,Ycas Joseph W.,Gandhi Sanjay K.,Miller Elinor

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers;Marcelino;Am J Med,1996

2. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals;Schectman;Am J Med,1996

3. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease [published correction appears in Am J Cardiol. 1999; 84:1143];Sueta;Am J Cardiol,1999

4. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals;Pearson;Arch Intern Med,2000

5. Cholesterol management in a population of managed care enrollees;Harley;J Clin Outcomes Manage,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials;Frontiers in Cardiovascular Medicine;2022-08-25

2. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over;International Journal of Clinical Pharmacy;2019-03-12

3. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia;Cardiovascular Journal of Africa;2018-07-02

4. Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs;Biostatistics;2018-04-18

5. Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study;Current Medical Research and Opinion;2017-09-18